ILSI North America,Washington DC, USA.
Nutr Rev. 2011 Jul;69(7):392-403. doi: 10.1111/j.1753-4887.2011.00402.x. Epub 2011 Jun 30.
Probiotics are live microorganisms that confer a health benefit on the host when administered in appropriate amounts. Over 700 randomized, controlled, human studies have been conducted with probiotics thus far, with the results providing strong support for the use of probiotics in the clinical prevention or treatment of gastrointestinal tract disorders and metabolic syndrome. The present review is based on webinar presentations that were developed by the American Gastroenterological Association (AGA) in partnership with the International Scientific Association for Probiotics and Prebiotics (ISAPP) and the North American branch of the International Life Sciences Institute (ILSI North America). The presentations provided gastroenterologists and researchers with fundamental and current scientific information on the influence of gut microbiota on human health and disease, as well as clinical intervention strategies and practical guidelines for the use of probiotics and prebiotics.
益生菌是指当给予适当剂量时，对宿主健康有益的活微生物。迄今为止，已经进行了超过 700 项随机、对照、人体研究，这些研究结果为益生菌在胃肠道疾病和代谢综合征的临床预防或治疗中的应用提供了强有力的支持。本综述基于美国胃肠病学协会（AGA）与国际益生菌和益生元科学协会（ISAPP）以及国际生命科学学会（ILSI）北美分会合作开发的网络研讨会演讲。这些演讲为胃肠病学家和研究人员提供了关于肠道微生物群对人类健康和疾病的影响的基本和当前科学信息，以及益生菌和益生元临床干预策略和实用指南。
